Racial disparities in the use of palliative therapy for ureteral obstruction among elderly patients with advanced prostate cancer

Supportive Care in Cancer

Volumn 21, Issue 5, 2013, Pages 1303-1311

  Spencer, Benjamin A ^a,b,c   Insel, Beverly J ^a,b   Hershman, Dawn L ^a,b   Benson, Mitchell C ^a   Neugut, Alfred I ^a,b  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^b Mailman School of Public Health   (United States)

^c New York Presbyterian Morgan Stanley Children's Hospital   (United States)

Author keywords

Hydronephrosis; Palliative care; Percutaneous nephrostomy; Prostate cancer; Racial disparity; Ureteral obstruction; Ureteral stent

Indexed keywords

ADVANCED CANCER; ADVANCED PROSTATE CANCER; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ARTICLE; HEALTH CARE DISPARITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PALLIATIVE THERAPY; PERCUTANEOUS NEPHROSTOMY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; RACE DIFFERENCE; RETROGRADE URETERAL STENT; RISK ASSESSMENT; SURVIVAL; URETER OBSTRUCTION; URETER STENT;

AFRICAN AMERICANS; AGE FACTORS; AGED; AGED, 80 AND OVER; DATABASES, FACTUAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; HEALTHCARE DISPARITIES; HUMANS; MALE; MEDICARE; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEPHROSTOMY, PERCUTANEOUS; PALLIATIVE CARE; PROSTATIC NEOPLASMS; SEER PROGRAM; STENTS; SURVIVAL RATE; UNITED STATES; URETERAL OBSTRUCTION;

EID: 84879695624     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-012-1666-6     Document Type: Article

References (19)

1. Kouba E, Wallen EM, Pruthi RS (2008) Management of ureteral obstruction due to advanced malignancy: optimizing therapeutic and palliative outcomes. J Urol 180:444-450
2. Wong LM, Cleeve LK, Milner AD, Pitman AG (2007) Malignant ureteral obstruction: outcomes after intervention. Have things changed? J Urol 178:178-183, discussion 83
3. Wilson JR, Urwin GH, Stower MJ (2005) The role of percutaneous nephrostomy in malignant ureteric obstruction. Ann R Coll Surg Engl 87:21-24
4. Ku JH, Lee SW, Jeon HG, Kim HH, Oh SJ (2004) Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: are there differences? Urology 64:895-899
5. Ganatra AM, Loughlin KR (2005) The management of malignant ureteral obstruction treated with ureteral stents. J Urol 174:2125-2128
6. Joshi HB, Stainthorpe A, MacDonagh RP, Keeley FX Jr, Timoney AG, Barry MJ (2003) Indwelling ureteral stents: evaluation of symptoms, quality of life and utility. J Urol 169:1065-1069, discussion 9
7. Shekarriz B, Shekarriz H, Upadhyay J et al (1999) Outcome of palliative urinary diversion in the treatment of advanced malignancies. Cancer 85:998-1003
8. Potosky AL, Riley GF, Lubitz JD, Mentnech RM, Kessler LG (1993) Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care 31:732-748
9. Du XL, Fang S, Vernon SW et al (2007) Racial disparities and socioeconomic status in association with survival in a large population-based cohort of elderly patients with colon cancer. Cancer 110:660-669
10. Klabunde CN, Potosky AL, Legler JM, Warren JL (2000) Development of a comorbidity index using physician claims data. J Clin Epidemiol 53:1258-1267
11. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373-383
12. Zeger SL, Liang KY, Albert PS (1988) Models for longitudinal data: a generalized estimating equation approach. Biometrics 44:1049-1060
13. Lee EW, Wei LJ, Amato DA, eds. Cox-type regression analysis for large numbers of small groups of correlated failure time observations; 1992.
14. Sandhu DP, Mayor PE, Sambrook PA, George NJ (1992) Outcome and prognostic factors in patients with advanced prostate cancer and obstructive uropathy. Br J Urol 70:412-416
15. Oefelein MG (2004) Prognostic significance of obstructive uropathy in advanced prostate cancer. Urology 63:1117-1121
16. Joshi HB, Adams S, Obadeyi OO, Rao PN (2001) Nephrostomy tube or 'JJ' ureteric stent in ureteric obstruction: assessment of patient perspectives using quality-of-life survey and utility analysis. Eur Urol 39:695-701
17. Hoffman RM, Gilliland FD, Eley JW et al (2001) Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study. J Natl Cancer Inst 93:388-395
18. Polednak AP (2003) Black-white differences in survival from late-stage prostate cancer. Ethn Dis 13:220-225
19. Radecka E, Magnusson M, Magnusson A (2006) Survival time and period of catheterization in patients treated with percutaneous nephrostomy for urinary obstruction due to malignancy. Acta Radiol 47:328-331